Oversight for clinical uses of autologous adult stem cells: lessons from international regulations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24315438.
- Also identified by DOI 10.1016/j.stem.2013.11.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autologous adult stem cells (ASCs) are being administered by physicians for indications that have not been demonstrated as safe and effective in formal clinical trials. Examination of regulatory frameworks across five countries suggests that balancing the demands of research with clinical freedom has created structural weaknesses that are being exploited.
Medical subject headings
- Adult Stem Cells
- Internationality
- Social Control, Formal
- Stem Cell Transplantation